TScan Therapeutics, Inc. (TCRX)
Market Open
26 Oct, 06:42 PM
NASDAQ (NMS) NASDAQ (NMS) Primary $
0. 18
-0.02
-9.2028%
$
14.67M Market Cap
- P/E Ratio
- Div Yield
655,036 Volume
-1.04 Eps
$ 0.2
Previous Close 
Want to track TCRX and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
| Name | Time | Cons. EPS | Eps |
|---|---|---|---|
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
TCRX Earnings Reports FAQ
What is the earnings per share (EPS) for TCRX?
The current EPS is -1.04.
What is the company's earnings growth rate?
TScan Therapeutics, Inc has not announced its next earnings release date. You can monitor upcoming announcements in Marketlog's earnings calendar or in the company profile.
When is the next earnings release date?
TScan Therapeutics, Inc has not announced its next earnings release date.
What were the most recent quarterly earnings?
The most recent quarterly earnings for TScan Therapeutics, Inc are not available at this time.
What is the price-to-earnings (P/E) ratio?
There is no P/E ratio for TCRX at this time, as TScan Therapeutics, Inc has no recent EPS data to calculate it.
2026 © Marketlog. All Rights Reserved.
